143 related articles for article (PubMed ID: 11640917)
1. alpha-Naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP3A6.
Boek-Dohalská L; Hodek P; Sulc M; Stiborová M
Chem Biol Interact; 2001 Oct; 138(1):85-106. PubMed ID: 11640917
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 3A expression and activity in the rabbit lacrimal gland: glucocorticoid modulation and the impact on androgen metabolism.
Attar M; Ling KH; Tang-Liu DD; Neamati N; Lee VH
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4697-706. PubMed ID: 16303967
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
Yamazaki H; Shimada T
Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486).
He K; Woolf TF; Hollenberg PF
J Pharmacol Exp Ther; 1999 Feb; 288(2):791-7. PubMed ID: 9918590
[TBL] [Abstract][Full Text] [Related]
6. Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes.
Kerlan V; Dreano Y; Bercovici JP; Beaune PH; Floch HH; Berthou F
Biochem Pharmacol; 1992 Nov; 44(9):1745-56. PubMed ID: 1449532
[TBL] [Abstract][Full Text] [Related]
7. Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N-demethylation. Competition during catalysis.
Wang RW; Newton DJ; Scheri TD; Lu AY
Drug Metab Dispos; 1997 Apr; 25(4):502-7. PubMed ID: 9107550
[TBL] [Abstract][Full Text] [Related]
8. Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes.
Pellinen P; Kulmala L; Konttila J; Auriola S; Pasanen M; Juvonen R
Arch Toxicol; 2000 Nov; 74(9):511-20. PubMed ID: 11131030
[TBL] [Abstract][Full Text] [Related]
9. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion.
Butler AM; Murray M
Mol Pharmacol; 1993 Jun; 43(6):902-8. PubMed ID: 8316222
[TBL] [Abstract][Full Text] [Related]
10. CYP3A inductive potential of the rifamycins, rifabutin and rifampin, in the rabbit.
Weber A; Kaplan M; Chughtai SA; Cohn LA; Smith AL; Unadkat JD
Biopharm Drug Dispos; 2001 May; 22(4):157-68. PubMed ID: 11745918
[TBL] [Abstract][Full Text] [Related]
11. Comparative inhibition of inducible and constitutive CYPs in rat hepatic microsomes by parathion.
Murray M; Butler AM
Xenobiotica; 2004 Aug; 34(8):723-39. PubMed ID: 15690761
[TBL] [Abstract][Full Text] [Related]
12. Cooperativity of alpha-naphthoflavone in cytochrome P450 3A-dependent drug oxidation activities in hepatic and intestinal microsomes from mouse and human.
Emoto C; Yamazaki H; Iketaki H; Yamasaki S; Satoh T; Shimizu R; Suzuki S; Shimada N; Nakajima M; Yokoi T
Xenobiotica; 2001 May; 31(5):265-75. PubMed ID: 11491388
[TBL] [Abstract][Full Text] [Related]
13. Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by alpha-naphthoflavone.
Schwab GE; Raucy JL; Johnson EF
Mol Pharmacol; 1988 May; 33(5):493-9. PubMed ID: 3367901
[TBL] [Abstract][Full Text] [Related]
14. Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolites.
Zhao XJ; Jones DR; Wang YH; Grimm SW; Hall SD
Xenobiotica; 2002 Oct; 32(10):863-78. PubMed ID: 12419016
[TBL] [Abstract][Full Text] [Related]
15. Meclizine, a pregnane X receptor agonist, is a direct inhibitor and mechanism-based inactivator of human cytochrome P450 3A.
Foo WY; Tay HY; Chan EC; Lau AJ
Biochem Pharmacol; 2015 Oct; 97(3):320-30. PubMed ID: 26239802
[TBL] [Abstract][Full Text] [Related]
16. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
Wen X; Wang JS; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
[TBL] [Abstract][Full Text] [Related]
17. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
[TBL] [Abstract][Full Text] [Related]
18. Mechanism-based inactivation of CYP2C11 by diclofenac.
Masubuchi Y; Ose A; Horie T
Drug Metab Dispos; 2001 Sep; 29(9):1190-5. PubMed ID: 11502726
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]